"PD-L1 inhibitors have significantly changed oncology [but] only about 30% of patients with cancer benefit from the drugs." Hurricane Maria's impact led to delays in care and uncertainty for patients with cancer in Puerto Rico. Dr. Andrew Hertler explains the FDA’s decision to narrow approvals for PD-1 inhibitors for stomach and esophageal cancers Potential microbial culprit behind the alarming rise in early-onset colorectal cancer: a bacterial toxin called colibactin. Factors such as long travel times to access care or limited parking options were reported as barriers to care. Dr. Bruce Dorr on what menopausal women with BRCA should know about hormone replacement therapy. Florida's demographics reflect what the US population could look like in the future in terms of aging and diversity. Gastric cancer represents one of America's most pronounced cancer disparities, with incidence rates 2 to 13 times higher. Patients with LIS subsidies were less likely to receive any systemic therapy compared with patients not receiving subsidies. Dr. Alessandra Maleddu discusses desmoid tumor, improving patient diagnosis and seeing a sarcoma specialist Researchers identified several socioeconomic and logistic barriers that limit diversity in clinical trials. Black patients had lower rates of utilization and longer wait times for immunotherapy. "... Though many newer therapies specifically target cancer cells, they can still interfere with heart function." This research promotes progress in understanding how tumor genetics differs across individuals of different ancestry. African American and Asian women had significantly lower odds of undergoing breast reconstruction. A drug used to treat some types of leukemia may offer patients with refractory multiple myeloma a new avenue for treatment. This risk poses serious challenges in urban environments. Residents may have limited access to fresh produce Neighborhood environment (eg, exposure to stressors, distance to treatment facilities) may contribute to poor survival. Dr. Terra Wonsettler discusses the cardiotoxicity among cancer drugs and cancer patient awareness of these risks. What goes on at a Hospice Meeting? Shocked 20-year-old diagnosed with CRC